In order to characterize fentanyl-related deaths in the province of Ontario, Canada, a 
Introduction
Fentanyl is a synthetic opioid analgesic and a potent IJ-agonist that is used clinically for the management of chronic pain and as an adjunctive anesthetic agent. In addition to these primary effects, agonist activity at the p-receptor can cause sedation and drowsiness, decreased gastrointestinal motility, mood alterations, euphoria, and mental clouding.
Fentanyl is available in its citrate form for oral transmucosal administration, as an injectable solution of fentanyl citrate, or in a transdermal delivery system (i.e., Duragesic). Aside from the drug's therapeutic applications, fentanyl is a potent drug of * Author to whom correspondence should be addressed. E-mail: teri.marlin@jus.gov.on.ca.
abuse. Abuse of fentanyl has included the use of illicit preparations of the drug and its homologues (e.g., "China White") (1, 2) , as well as the diversion of clinical preparations of fentanyl. In particular, the abuse of transdermal fentanyl patches has received increasing attention in recent years (3, 4) . The abuse of fentanyl patches by the non-treatment population is not restricted to transdermal application and reports of intravenous injection of patch contents (5-7), oral transmucosal abuse (8) (9) (10) ; rectal insertion (11) ; and volatilization and inha]ation of fentanyl patches (12) have been published.
The toxicity of fentanyl is well-documented and is similar to other opioids. One of the main concerns following fentanyl administration is respiratory depression which can be pronounced even among the clinical population receiving fentanyl under medical supervision. Fentanyl, like all IJ-agonists, depresses the respiratory centers in the brain stem, decreases respiratory rate and tidal volume, and reduces the sensitivity of the respiratory center to carbon dioxide (CO2) (13) . Accordingly, severe respiratory depression and deaths due to respiratory failure have been reported among both treatment (14, 15) and non-treatment populations (4) . Other toxic effects of fentanyl include central nervous system (CNS) depression, bradycardia, and hypotension. Furthermore, fentanyl concurrently depresses the cough reflex and stimulates the chemoreceptor trigger zone, inducing nausea and vomiting, which presents a risk for aspiration.
Given the prevalent use of fentanyl for the treatment of chronic pain and the high abuse potential of the drug, an understanding of the range of blood fentanyl concentrations encountered for a variety of types of postmortem forensic cases is required. The objective of the current study was to enhance this understanding and elucidate the types of fentanyl abuse that can occur through a large-scale retrospective analysis of fentanyl-positive deaths in the province of Ontario, Canada over a three-year period. A thorough analysis of these deaths provides comparative blood concentrations for various routes of administration, and detailed histories of select cases are presented to further characterize the circumstances surrounding different types of fentanyl-related deaths.
Methods

Case selection
The Office of the Chief Coroner (OCC) performs 20,000 coroner's death investigations annually in the province of Ontario, Canada (approximate population: 12 million) with 4500 cases submitted to the Centre of Forensic Sciences (CFS) and Northern Regional Laboratory (NRL) for toxicological analysis.
One-hundred twenty cases in which fentanyl was detected were identified from the files of the CFS and NRL with additional case history information obtained from the OCC, including the circumstances of death, autopsy findings, police reports (where applicable) and cause and manner of death.
Inclusion criteria for this study were 1. death occurring during the time period between January 1, 2002 and December 31, 2004; 2. the detection of fentanyl at a quantifiable concentration (> 1.25 IJg/L); and 3. quantitation of fentanyl performed in a blood sample collected from an intact vessel. In the vast majority of cases, quantitation occurred in a postmortem blood sample; however, in two cases, only antemortem fentanyl concentrations were determined.
Analytical methods
The CFS and NRL do not use a screening method to detect the presence of fentanyl; thus, all cases in which fentanyl was quantitated were cases in which targeted analysis for the drug had been performed.
Fentanyl and fentanyl-d~ were purchased from Cerilliant (Round Rock, TX). Stock standards were prepared in methanol and stored at -15~ The calibration curve was prepared from drug-flee blood to five final concentrations: 2.5, 5, 10, 20, and 40 pg/L. Fifty microliters of internal standard (fentanyl-ds: 800 lJg/L) was added to calibrators, positive controls, negative controls, and case samples. The extraction procedure was a modified liquid-liquid method previously described by Koves and Wells (16) . Briefly, 7.0 mL of toluene and 100 IJL of ammonium hydroxide (NH4OH) were added to 2.0 mL of whole blood and rotated for 20 rain. The mixture was centrifuged at 2400 rpm for 10 rain at 10~ and the upper organic phase was transferred to a clean test tube. To the organic phase, 2.0 mL of 2.0N sulfuric acid (H2SO4) was added, vortex mixed for 60 s, and centrifuged at 2400 rpm for 5 rain at 10~ The upper organic phase was aspirated and discarded. The remaining aqueous acid layer was placed into a freezer for approximately l0 rain. It was subsequently made alkaline by the dropwise addition of 5.0N sodium hydroxide (NaOH) and extracted with 1.0 mL of toluene. After centrifugation for 5 rain at 2400 rpm at 10~ the organic phase was transferred to an automatic injector vial and evaporated to dryness under nitrogen, without heat. Reconstitution was in toluene (50 lJL). Microvials were sealed with Teflon| caps. Samples were analyzed using a Hewlett-Packard 5970 (Palo Alto, CA) or Agilent 5973 (Palo Alto, CA) gas chromatography-mass spectrometry (GC-MS) system equipped with an autosampler. A 2-]~L aliquot of the extract was injected on to a DB-5 column (30 m x 0.25-ram i.d., 0.25-]Jm thickness, J&W Scientific) with helium as the carrier gas at a flow rate of 0.6 mL/min. The inlet temperature was maintained at 270~ The GC oven temperature was programmed as follows: 100~ for 1 min, then increased at a rate of 25~ to a final temperature of 290~ for 12 min (total run time: 21 min). The transfer line temperature was 290~
The MS was operated in the electron-impact ionization positive ion mode with a source temperature of 200~ Selected ion monitoring (SIM) was used to scan three ions for fentanyl (m/z 146, 189, 245) and fentanyl-ds (m/z 151, 194, 250) with dwell times of 100 ms for all ions monitored.
Quantitation was performed by taking the mean of results obtained from two calibration curves: using the m/z 146 and 151 fentanyl and fentanyl-ds ions and the m/z 245 and 250 fentanyl and fentanyl-ds ions. Intra-and interday validation studies have demonstrated the linear range of this method to be 1.25 to 40 IJg/L and the sensitivity to be less than 0.63 IJg/L. In circumstances where there was insufficient case blood available for analysis, volumes were brought up to 2.0 mL with blank blood and a dilution factor was taken into account. Results obtained outside the calibration range of the method were re-extracted using a smaller aliquot of case blood and made up to the required volume with drug-free blood.
Results and Discussion
Of the 120 fentanyl-positive cases initially identified, 112 met the inclusion criteria for this study. There were 20 fentanyl-related deaths in 2002, whereas in 2003 and 2004, the number of cases increased to 35 and 57, respectively. Overall, the cases comprised 63 males and 49 females with ages ranging from 4 to 93 years (median: 45 years). Cases were categorized according to the medical cause of death (Table I ). Blood concentrations of fentanyl observed for all subjects ranged widely from 2.7 to 383 l~g/L (Table I ). There were two cases in which there was significant underlying pathology, and the role of fentanyl in the death could not be determined, preventing their inclusion in Table I . The first case involved a 93-year-old male who had underlying pathology considered sufficient to have caused his death, but also recently received an increase in his fentanyl dosage. The significance of the increased fentanyl dosage could not be elucidated and as a result, the final cause and manner of death were ruled to be undetermined. In the second case, a 46-year-old male had recently been prescribed fentanyl as an alternative to sustained-release morphine for control of neuralgic-type chronic pain. At autopsy, a perforated duodenal ulcer was detected with approximately 1 L of blood in the abdomen. The cause of death was ruled to be a combination of medical and toxicological reasons (perforated duodenal ulcer, fentanyl toxicity), and the manner of death was undetermined. Although these two decedents were excluded from Table I , their associated data were included in all subsequent analyses. There were 54 cases identified in which fentanyl alone was considered to have caused death (Table I) . Of these 54 deaths, 38 were considered to have been accidental fentanyl overdoses, 14 cases had an undetermined manner, and two cases were suicidal administrations.
Concomitant drug administration
The co-administration of other drugs with fentanyl was common and 31 deaths were attributed to mixed drug toxicity (14 accidental deaths, 13 undetermined deaths, and 4 suicides). Table II reports the other drug findings in the cases where death was due to mixed drug toxicity. The most common co-intoxicants in the cases of combined drug toxicity were other opioid-type drugs, particularly oxycodone (n = 10) and morphine (n = 7). Also prevalent was diphenhydramine, which was present in 10 cases of mixed-drug intoxication at quantifiable amounts and in an additional four cases at trace levels (< 0.13 mg/L). Antidepressants of the selective-serotonin reuptake inhibitor (SSRI) type [i.e., citalopram (n = 6), fluoxetine/norfluoxetine (n = 5), paroxetine (n = 2), and ser- traline (n = 1)] were also commonly detected. The finding of other opioids along with fentanyl in the blood of mixed drug toxicity deaths is consistent with the observations of Kuhlman et al. (4) . In their review, 11 of 23 cases contained at least one additional opioid with the most frequently occurring opioid being oxycodone. Antidepressants were also frequently detected in these cases. Such observations are not surprising considering that poly-pharmacy among patients with cancer and other severe pain syndromes is common. Although tolerance to opioids will affect the level of toxicity that would be expected in these cases, the combined effects of multiple opioids would be expected to be at least additive. Similarly, the co-administration of other CNS depressants would be expected to produce additive toxicity.
Combined fentanyl and ethanol toxicity
Deaths due to combined fentanyl and ethanol intoxication were considered separately from other mixed-drug deaths and accounted for nine cases. Although other drugs were detected in addition to fentany] and ethanol in many of these cases, the presence of those drugs was not considered to have contributed to the death of the individual. Blood-alcohol concen- trations (BAC) for each of the decedents are provided in Table  III . In all cases, the BAC exceeded 100 mg/dL. Given the additive respiratory and central nervous system depressant effects between fentanyl and ethanol it was expected that deaths due to combined fentanyl and ethanol toxicity would be associated with lower fentanyl blood concentrations than deaths reported to have been due to fentanyl alone. Although the average fentanyl concentration in the combined ethanol and fentanyl deaths was lower (16 pg/L) than among deaths attributed solely to fentanyl (25 pg/L), they were not found to be significantly different by statistical analysis (Student t-test, p > 0.05). This point is further illustrated when the minimum fentanyl concentrations associated with death are examined. Death due to fentanyl alone was associated with blood concentrations as low as 3.0 lag/L, whereas the minimum fentanyl concentration associated with death due to the combined effects of ethanol and fentanyl was 6.4 pg/L Thus, although the combined effects of another CNS and respiratory depressant, such as ethanol, with fentanyl can be expected to produce additive toxicity, this pharmacological interaction is not necessarily reflected in the blood fentanyl concentrations observed.
Incidental fentanyl findings
There were 16 cases in which fentanyl could be classified as an incidental finding: 11 natural deaths, 3 traumatic or other non-drug cause of death cases, and 2 individuals for whom death was attributed to an overdose with a drug other than fentanyl. There was an overlap in the blood concentrations observed in these non-fentanyl deaths compared to the deaths in other categories (Table I) . For example, the lowest fentanyl concentration observed among the deaths attributed only to fentanyl toxicity was 3.0 lag/L, and a concentration of 33 pg/L was measured in a death due to natural causes. Such overlapping concentration ranges are inevitable in forensic cases involving opioid administration because the toxicity of these compounds is significantly influenced by the acquired tolerance of an individual to the drug. Natural deaths, along with cases where death was attributed to other, non-fentanyl causes provide the forensic toxicologist with exemplars of drug concentrations that may be survivable by chronic users. In a review of 25 postmortem cases, Anderson and Nuto (3) also provided data for deaths that were classified as "clearly not fentanyl-related". The concentrations observed in their cases, however, were )ower than the concentrations observed here and were more consistent with the concentrations reported in clinical studies. In their eight cases, postmortem heart blood levels ranged from 2 to 7 lag/L (mean: 3.6 lag/L) (3). By comparison, in clinical studies where transdermal fentanyl is received by postoperative or cancer patients for pain management, serum concentrations of less than 5 lag/L have typically been reported (17, 18) . The observation that blood concentrations among the natural deaths in the current study exceed previously reported values may be a reflection of more tolerant users of the drug among our decedents. Indeed the po-tential for extreme tolerance to fentanyl has previously been depicted in a report of a woman receiving 3400 IJg/h of transdermal fentanyl and achieving a plasma concentration of 178 IJg/L without experiencing serious toxicity (19) .
Route of fentany] administration
In the majority of our cases (55%), the route of fentanyl administration prior to death was clearly identified as transdermal absorption via Duragesic patches (Figure 1 ). Blood concentrations where only transdermal administration was believed to have occurred ranged from 3.0 IJg/L to 71 IJg/L with a mean and median of 15 lag/L and 12 IJg/L, respectively.
The number of men and women whose deaths occurred following transdermal use was evenly distributed: 48% were men and 52% were women, and the range of ages (17-93 years) approximated the data set as a whole. In contrast, the decedents who had administered fentanyl intravenously were predominantly male (86%, Table IV ). The range of ages of individuals who injected fentanyl (24-54 years) was also compressed compared to the overall data set (4-93 years), with 64% of users between 35 and 54 years, illustrating that this route of administration is largely attributed to middle-aged men. Twelve of the individuals who had injected fentanyl were believed to have used this route of administration exclusively at the time of death, whereas in two cases there was evidence for combined intravenous and transdermal administration (Table IV) . In 10 cases, there was clear evidence that the source of injected fentanyl was the contents of a Duragesic patch: the median fentanyl concentration among this subgroup was 22 IJg/L with a range of concentrations from 3 to 383 pg/L. In one case of injection that did not appear to involve patch extraction, the decedent had a subclavian vein Hickman catheter for intravenous pump infusion of both hydromorphone and fentanyl (subject 68 in Table IV) , whereas in another case (subject 6 in IV), a medical bottle containing a small amount of clear fluid was noted at the scene. This decedent was a registered nurse who performed in-home care and thus may have had access to injectable solutions of fentanyl citrate; however, the actual source of fentanyl in this case could not be positively identified.
Of note was the fact that the cause of death in most of the intravenous cases was attributed solely to fentanyl intoxication (Table IV) . These results show that deaths due to fentanyl overdose following intravenous injection can occur at blood concentrations as low as 3.0 IJg/L, which supports the conclusions of other researchers. For example, blood concentrations ranging from 3 to 27.5 pg/L were observed in four cases of death following self-injection of fentanyl citrate solution (20) (21) (22) (23) , whereas in five deaths attributed to the injection of the contents of Duragesic patches, blood concentrations ranged from 2.0 to 27 I~g/L (4,6,7).
It was anticipated that fatal blood concentrations observed where death occurred following intravenous injection would be lower than those arising following the transdermal route of administration. Given the high lipophilicity of fentanyl and the rapidity with which an injected drug enters the blood, the intravenous route of administration is associated with the fastest speed of onset of pharmacological action, including toxic effects. Thus, a dose that might potentially be survivable following transdermal administration may be provided too rapidly via intravenous administration resulting in death at lower concentrations. Indeed, previous case reports have shown that death due to the self-injection of fentanyl has been associated with concentrations as low as 2 pg/L (7), whereas reports of death due to transdermal fentanyl administration have been associated with blood concentrations of 12 IJg/L and greater (3). This hypothesis was not supported by the current data (Table V) , which show that when the cause of death was fentanyl toxicity, the transdermal and intravenous administration routes were associated with fatality at concentrations as low as 4.0 and 3.0 IJg/L, respectively. Furthermore, the difference in mean fentanyl concentrations between the groups was not statistically significant (Student t-test, p > 0.05). It is noteworthy, however, that the maximum concentration of fentanyl observed following the intravenous route of administration was much greater than the maximum blood concentration achieved following transdermal administration (Table V) . This finding of a blood concentration of 383 l~g/L in a case of accidental overdose probably reflects a rapid death following a bolus injection of the drug. Although the precise dose of fentanyl injected cannot be determined for this subject, it was noted in his case that there were five Duragesic-50 patches missing from a prescription filled two days prior. Other evidence from the scene, including the presence of a syringe in close proximity (less than 1.5 m) to the deceased and a venous puncture wound with dried blood, lend further support to the conclusion that death was rapid. Although less prevalent, two unusual routes of drug administration were observed among the fentanyl-related deaths examined. In seven cases the contents ofa Duragesic patch were ingested orally prior to death, including one death where a combined oral/transmucosal and transdermal route of administration was employed (24) . The cases involving oral ingestion comprised 3 women and 4 men ranging in age from 20 to 51 years. The range of postmortem blood fentanyl concentrations observed was 7-97 I~g/L (mean: 28 IJg/L). Although it represents an unusual method of drug abuse, other reports of oral administration of fentanyl patches have been described (9, 10, 25) .
There was a single case during the study period in which the contents of a transdermal fentanyl delivery system were inhaled. A detailed case history for this decedent is provided here subsequently.
Although the route of fentanyl administration prior to death was able to be determined in most cases, there were numerous cases in which the information surrounding death was insufficient to positively identify the means of drug delivery. In total, 28 cases were recorded as an "unknown" route of fentanyl administration (Figure 1) . It was similarly difficult in many cases to determine the source of fentanyl that was detected; in 42 of the 112 deaths (38%) the origins of the drug were unknown. Of the remaining cases, most individuals (n = 59) had their own prescriptions for fentanyl. Other deaths occurred following the use of fentanyl that had been prescribed to a friend or family member (n = 10). There was only one case in which the use of street-purchased fentanyl could be conclusively identified. In this case it was known that the deceased had illicitly purchased Duragesic-50 patches. It is likely, however, that many of the deaths for whom the source of drug was unknown would also fall into this category because the absence of information in these cases is partly due to a lack of prescription for the drug by either the decedent or a member of the decedent's household.
Although an investigation into site-dependent differences in postmortem fentanyl concentrations was not a focus of the current study, both heart and peripheral blood concentrations were available in four cases. Peripheral blood fentanyl concentrations for these cases ranged from 8 IJg/L to 28 I~g/L with an average heart/peripheral blood ratio of 1.13 (range: 1.11-1.14). By comparison, in 13 cases where both heart and femoral blood fentanyl concentrations were previously reported, a mean heart/femoral blood ratio of 1.62 was reported with a range of 0.70 to 4.58 (3) . In one other case, a heart blood fentanyl concentration of 6.05 1Jg/L was recorded in the presence of a femoral blood concentration of 2.66 l~g/L (heart/femoral = 2.27) (12) . Finally, a more recent case, analyzed by this laboratory in 2005 demonstrated a heart/femoral blood concentration ratio of 1.42. The wide variability among these data suggest that further examination regarding sitedependent differences in postmortem fentanyl levels is warranted. In some cases (i.e., rapid deaths), incomplete distribution of the drug (rather than redistribution of fentanyl after death) could also account for differences in peripheral and heart blood concentrations.
Selected case histories
Six cases were identified that were of particular interest due to their comprehensive case histories and/or the circumstances surrounding the death. Reports of those cases are presented to further characterize the types of deaths that can occur following fentanyl administration and the significance of the findings are discussed.
Subject 89. This case depicts a natural death following the transdermal administration of fentanyl. The deceased is a 59-year-old woman who was found lying dead in a prone position at her home. She had a prescription for transdermally administered fentanyl for pain management related to rheumatoid arthritis and prescriptions for amlodipine besylate (i.e., Norvasc | and ramipril for the treatment of high blood pressure. Postmortem pathological examination revealed hypertensive coronary artery disease. Fentanyl was quantitated in a postmortem femoral blood sample at a concentration of 12 IJg/L. The only other toxicological findings were traces of chlorpheniramine and amlodipine. Ethanol and other volatiles were not detected, and there were no other significant findings by a GC and GC-MS screen for chemically basic drugs. The cause of death was listed as coronary artery disease, and the manner of death was natural.
Subject 16. The decedent in this case is a four-year-old developmentally delayed child who died in hospital following a history of spastic hemiplegia, metabolic disorder, and mild asthma. He was admitted to hospital for surgery (bilateral Achilles tendon lengthening and bilateral varus osteomies) where he developed a croupy cough and became O2-dependent. He decompensated three-days postsurgery and was transferred to the intensive care unit. He had pulseless electrical activity (PEA) and pulmonary edema. In spite of prolonged resuscitation, he was ultimately pronounced dead. At autopsy, acute, extensive bronchopneumonia involving both the left lower and left upper lobes of the lung was noted. Toxicological analysis revealed a postmortem femoral blood fentanyl concentration of 3.8 1Jg/L. Other drugs present were morphine (0.061 rng/L) and acetaminophen (13 rag/L). Bupivacaine was detected but not quantitated. There were no other significant findings including a GC and GC-MS screen for chemically basic drugs. The cause of death was pneumonia, and the manner was natural. There is a paucity of literature regarding expected fentanyl concentrations in children following therapeutic administration. This case is significant as it provides a postmortem blood fentanyl concentration in a child where the presence of the drug was considered incidental to death.
Subject 85. This case involves a 46-year-old woman who had arrived at a friend's home drowsy and requiring frequent wakening while engaged in conversation. She elected to lie down and was found sometime later without vital signs. Resuscitation attempts at hospital were to no avail. She had a history of prescriptions for Duragesic and hydromorphone for the treatment of headaches. Postmortem examination revealed acute congestion and edema of the lungs with patchy bronchopneumonia and a femoral blood fentanyl concentration of 12 ~g/L. Aside from a therapeutic concentration of venlafaxine (< 0.4 mg/L), there were no other major toxicology findings despite comprehensive drug screening. There was further case history that the deceased was taking Kaletra | an anti-retroviral formulation containing lopinavir and ritonavir in combination; however, toxicology methods to confirm the presence of these two drugs were not available to this laboratory. The possibility of simultaneous use of lopinavir, ritonavir, and fentanyl is significant as the protease inhibitors, particularly ritonavir, are potent inhibitors of the cytochrome P450 (CYP) 3A4 enzyme system (26, 27) . Because fentanyl metabolism occurs mainly by CYP 3A4, inhibition of this enzyme system may result in decreased clearance and prolonged fentanyl half-life (27, 28) . Accordingly, health professionals are cautioned against the concomitant use of these drugs (29) . In the present case, the cause of death was concluded to be an accidental fentanyl overdose as a consequence of drug interaction with Kaletra | thereby providing a forensically relevant example of a pharamacokinetic interaction previously identified by clinical study (27) .
Subject39. The decedent in this case is a 45-year-old woman who was found without vital signs and lying on the floor of her secure apartment. She had a history of chronic pain, peripheral vascular disease, arteriosclerosis and chronic depression and was followed regularly by both a general physician and psychiatrist. Numerous prescriptions were present in the home including fentanyl, citalopram, quetiapine, doxepin, lorazepam, and zopiclone. At the time of her death she was found to be wearing eight of her Duragesic (75 IJg/h) patches, contrary to her prescribed dose of one patch every 72 h. There was a history of at least one previous attempted-suicidal drug overdose. Toxicological analyses revealed a femoral blood fentanyl concentration of 19 IJg/L. Citalopram (1.1 rag/L) was also detected. Neither quetiapine nor doxepin was present. Analyses for lorazepam and zopiclone were not performed based on the case history and the fentanyl finding. The cause of death was attributed to suicide by fentanyl overdose.
Subject24.
A 34-year-old male and known drug abuser with a history of intravenous cocaine use reported to a relative that he was going to "shoot up". He subsequently indicated that it was "hitting him really hard", and just prior to death, he reported that he had mistakenly injected a "100-rag morphine patch". Within moments, he was reported to lose consciousness and stop breathing. Syringes, spoons, and an empty Duragesic-100 transdermat fentanyl system were found at the scene. At autopsy, four fresh puncture wounds were present on the skin of the left antecubital fossa. Pulmonary edema and congestion were also identified. Fentanyl was determined in a submitted heart blood sample at a concentration of 22 IJg/L. Although traces of benzoylecgonine were also detected, there were no other significant toxicological findings. Death was considered to be due to an accidental overdose of fentanyl. A 100 IJg/h Duragesic system contains a total fentanyl content of 10 mg. This case presents a unique situation in which the dose of fentanyl injected following extraction of patch contents is apparently known. Considering other case reports where the contents of 100 lag/h transdermal fentanyl patches were injected, it would appear that resultant blood concentrations may be variable. For example, in two other such cases, postmortem blood concentrations were 2.7 ,g/L and 13.8 ,g/L (5). The variability observed in postmortem blood concentrations where apparently similar doses of fentanyl have been injected demonstrates that calculation of dose administered from a resultant blood level should not be performed in postmortem cases. Aside from interindividual differences in the pharmacokinetics of the drug, the rapidity of death and the amount of fentanyl extracted the patch and injected can also contribute to these varying postmortem concentrations.
Subject 103. The final case describes a death following the inhalation of fentanyl. This 32-year-old man was known to abuse heroin, methadone, and cocaine and had developed a system to extract and inhale fentanyl from Duragesic patches, which had been prescribed to his father. On the date of his death, he was found seated and unresponsive. A suspected cannabis product, torch, and aluminium foil with burnt white residue were found at the scene. Resuscitative efforts were unsuccessful. No puncture marks could be identified at autopsy. Toxicological testing showed indications of cannabinoid metabolites along with a femoral blood fentanyl concentration of 5.8 lJg/L. Methadone, morphine, and cocaine were not detected, nor were there any additional findings by a GC and GC-MS basic drug screen. The cause of death was fentanyl overdose, and the manner of death was concluded to be accidental. The blood concentration in this case is higher than one other case of fentanyl inhalation previously described (12) . In that case, a 36-year-old male with a history of scraping and heating the contents of fentanyl patches for inhalation purposes was found dead following an inhalation session. A postmortem femoral blood concentration of 2.71Jg/L was measured in that individual (12) .
Conclusions
Fentanyl is a potent opioid analgesic with high desirability as a drug of abuse. The results of this retrospective study illustrate that there are numerous circumstances under which fentanyl may arise in forensic casework. In particular, there are several means of illicit fentanyl abuse, including oral administration, injection of the contents of transdermal fentanyl systems, and volatilization and inhalation of fentanyl patch contents. This study further provides valuable information on the wide range of fentanyi concentrations observed in individuals in deaths that have been attributed to fentanyl toxicity compared to deaths where fentanyl was considered an incidental finding. The significant overlap between those blood concentrations reemphasizes that interpretations of postmortem drug concentrations must be made within the context of the overall death investigation, where acquired tolerance, medical history, and pathological findings are all critical issues to be considered in determining the cause of death.
